Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

GANXGANX
Showing 8 of 16 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in GAIN THERAPEUTICS INC

NORTHERN TRUST CORP holds 97,013 shares of GANX (GAIN THERAPEUTICS INC), worth $196,936 as of 2026-Q2. The position was decreased (-14.9% shares).

Current Value

$196,936

Current Shares

97,013

Total Value Change

+$116,936

Total Shares Change

+52,069

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
97,013
-14.9%
$196,9360.0%$2.03
0
2026-Q1
Increased
113,997
+11.8%
$221,1540.0%$2.63
17
2025-Q4
Increased
102,001
+15.4%
$328,4430.0%$3.05
18
2025-Q3
Decreased
88,399
-11.8%
$156,4660.0%$1.81
0
2025-Q2
Unchanged
100,170
0.0%
$180,3060.0%$1.97
0
2025-Q1
Increased
100,170
+18.4%
$191,3250.0%$1.89
18
2024-Q4
Increased
84,586
+88.2%
$182,7060.0%$2.18
24
2024-Q3
Unchanged
44,944
0.0%
$80,0000.0%$1.99
0

Other major holders of GANX: GREENLIGHT CAPITAL INC, Gotham Asset Management, LLC, MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used